Practice Patterns and Outcomes of Online Hemodiafiltration: A Real-World Evidence Study in a Russian Dialysis Network

Author:

Neri Luca,Gurevich Kostantin,Zarya Yana,Plavinskii Svyatoslav,Bellocchio Francesco,Stuard StefanoORCID,Barbieri Carlo,Canaud Bernard

Abstract

<b><i>Background:</i></b> Evidence suggests that online hemodiafiltration (OL-HDF) is associated with improved survival. Whether the dose-response relationship between convective volume and mortality may be confounded by selection bias or descends from practice patterns is not clear. We sought to evaluate the role of patients’ characteristics and practice patterns on OL-HDF dose and mortality in a large private dialysis network in the Republic of Russia. <b><i>Methods:</i></b> In this multicenter, historical cohort study, we included adult incident patients on OL-HDF with at least 90 days of survival on renal replacement therapy in centers belonging to the Russian Federation Fresenius Medical Care network (January 1, 2011, to December 31, 2016). We evaluated predictors and outcomes (survival) of substitution volume target achievement (<i>Q</i><sub>sub</sub> &#x3e; 21 L/session). <b><i>Results:</i></b> Among 1,081 enrolled patients, the average <i>Q</i><sub>sub</sub> was 22.9 (±3.2) L/session; the mean ultrafiltration volume was 1.6 (±0.8) L/session. The mean age was 55.8 ± 13.2; 42% were woman. Most common comorbidities were congestive heart failure (39.7%) and peripheral vascular disease (21.7%). The average hemoglobin was 9.3 ± 1.3. The case-mix adjusted center effect accounted for 20% of variance in <i>Q</i><sub>sub</sub>. The top 10 most important variables associated with higher <i>Q</i><sub>sub</sub> were effective <i>Q</i><sub>b</sub>, serum protein, Charlson’s comorbidity index, hemoglobin, year of dialysis initiation (proxy of high <i>Q</i><sub>sub</sub> treatment policy in the clinic network), predialysis heart rate, serum bicarbonate, serum phosphate, age, serum sodium, and dry body weight. In addition, we found that the association of <i>Q</i><sub>b</sub> with <i>Q</i><sub>sub</sub> is moderated by year of enrollment, intradialytic weight gain, and coronary artery disease, whereas higher hemoglobin concentration moderated the relationship between treatment time and <i>Q</i><sub>sub</sub>. Finally, <i>Q</i><sub>sub</sub> between 21 and 25 L/session was associated with longer 5-year survival. <b><i>Conclusions:</i></b> Both center-dependent clinical practice standards and patient clinical conditions substantially contributed to the risk of low <i>Q</i><sub>sub</sub>. We confirmed previous evidence indicating better survival among patients with <i>Q</i><sub>sub</sub> ≥ 21 L/session.

Publisher

S. Karger AG

Subject

Nephrology,Hematology,General Medicine

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3